US Patent Issued to Albert Einstein College of Medicine on Aug. 18 for "Small molecule BAX inhibitors and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,621, issued on Aug. 18, was assigned to Albert Einstein College of Medicine (Bronx, N.Y.).

"Small molecule BAX inhibitors and uses thereof" was invented by Evripidis Gavathiotis (Roslyn, N.Y.), Richard N. Kitsis (New York), Thomas Peter Garner (Long Island City, N.Y.), Dulguun Amgalan (Bronx, N.Y.), Lorrie Kirshenbaum (Winnipeg, Canada) and Felix Kopp (Brooklyn, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, compositions and method of using these compounds are disclosed for treating a disease or disorder in which it is desirable to inhibit BAX, such as a cardiovascular disease or disorder."

The patent was filed on March 5, 2024, und...